# Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)

Study · id `cardio:ct-nct03672097` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03672097](<https://clinicaltrials.gov/study/NCT03672097>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03672097

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 204 participants.

## Technical summary

Registry record NCT03672097. Allocation not applicable; no masking; primary purpose treatment. Start 2018-10-16 (actual); primary completion 2020-08-19 (actual). Results posted on 2021-11-12.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 204 participants (enrolled count; ClinicalTrials.gov record NCT03672097, source copy `cardio:ctgov-nct03672097-2021-11-12`, retrieved 2026-10-26)
- Started: 2018-10-16 (actual) (ClinicalTrials.gov record NCT03672097, source copy `cardio:ctgov-nct03672097-2021-11-12`, retrieved 2026-10-26)
- Primary completion: 2020-08-19 (actual) (ClinicalTrials.gov record NCT03672097, source copy `cardio:ctgov-nct03672097-2021-11-12`, retrieved 2026-10-26)
- Completion: 2020-08-19 (actual) (ClinicalTrials.gov record NCT03672097, source copy `cardio:ctgov-nct03672097-2021-11-12`, retrieved 2026-10-26)
- Results first posted: 2021-11-12 (ClinicalTrials.gov record NCT03672097, source copy `cardio:ctgov-nct03672097-2021-11-12`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT03672097, source copy `cardio:ctgov-nct03672097-2021-11-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03672097-2021-11-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)
- Condition: Acute Coronary Syndrome (ACS)
- Intervention (Drug): Prasugrel
- Lead sponsor: Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)

## Provenance

Content hash: 9436ae4010a1f306e6eb75581074dcec1db14be672eb983d84225f7e9fa5e6f1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
